Xilio Therapeutics News - XLO

Company Name	Stock Ticker Symbol	Market	Type
Xilio Therapeutics Inc	XLO	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.00	0.00%	1.05	20:00:00

Open Price	Low Price	High Price	Close Price	Prev Close
				1.05

more quote information »

Recent News

Date	Time	Source	Heading
4/01/2024	16:05	GLOBE	Xilio Therapeutics Announces Pipeline and Business Updates..
3/28/2024	07:05	GLOBE	Xilio Therapeutics Announces $11.3 Million Private Placement..
3/28/2024	07:00	BW	Gilead and Xilio Announce Exclusive License Agreement for..
2/28/2024	16:01	GLOBE	Xilio Therapeutics to Participate in Novel Immuno-Oncology..
1/31/2024	16:01	GLOBE	Xilio Therapeutics to Present at Guggenheim 6th Annual..
1/19/2024	16:30	EDGAR2	Form 8-K - Current report
1/08/2024	07:30	GLOBE	Xilio Therapeutics Highlights Recent Advances Across..
1/03/2024	16:38	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/03/2024	16:15	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/03/2024	16:15	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/03/2024	16:05	EDGAR2	Form 8-K - Current report
12/07/2023	07:45	EDGAR2	Form 8-K - Current report
12/07/2023	07:30	GLOBE	Xilio Therapeutics Announces Initiation of Enrollment for..
11/09/2023	16:17	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/2023	16:13	EDGAR2	Form 8-K - Current report
11/09/2023	16:10	EDGAR2	Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
11/09/2023	16:08	EDGAR2	Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
11/09/2023	16:05	EDGAR2	Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
11/09/2023	16:01	GLOBE	Xilio Therapeutics Announces Pipeline and Business Updates..
11/03/2023	16:05	EDGAR2	Form 8-K - Current report
11/03/2023	12:00	GLOBE	Xilio Announces Initial Monotherapy Safety and Anti-Tumor..
10/31/2023	09:15	GLOBE	Xilio to Host Virtual Investor Conference Call and Webcast..
9/27/2023	17:02	GLOBE	Xilio Therapeutics Announces Upcoming Presentations at the..
9/07/2023	16:26	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/07/2023	16:23	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
9/05/2023	08:35	EDGAR2	Form 8-K - Current report
9/05/2023	08:30	GLOBE	Xilio Therapeutics Announces Promotion of Katarina..
9/05/2023	07:30	GLOBE	Xilio Therapeutics to Present at Morgan Stanley 21st Annual..
8/18/2023	20:40	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/18/2023	20:35	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/14/2023	07:45	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/14/2023	07:40	EDGAR2	Form 8-K - Current report
8/14/2023	07:30	GLOBE	Xilio Therapeutics Announces Pipeline and Business Updates..
8/07/2023	16:12	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/07/2023	16:09	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
8/03/2023	16:15	EDGAR2	Form 8-K - Current report
8/03/2023	16:05	GLOBE	Xilio Therapeutics Announces Promotion of Chris Frankenfield..
5/25/2023	17:01	GLOBE	Xilio Therapeutics Announces Preliminary Clinical Data from..
5/09/2023	07:30	GLOBE	Xilio Therapeutics Announces Pipeline and Business Updates..